Wu, Huanwen
Guo, Shiwei
Liu, Xiaoding
Li, Yatong
Su, Zhixi
He, Qiye
Liu, Xiaoqian
Zhang, Zhiwen
Yu, Lianyuan
Shi, Xiaohan
Gao, Suizhi
Wang, Huan
Pan, Yaqi
Ma, Chengcheng
Liu, Rui
Dai, Menghua
Jin, Gang
Liang, Zhiyong http://orcid.org/0000-0003-4787-2925
Funding for this research was provided by:
National Key Research and Development Project of China (2017YEFD110300, 2019YFC1315904)
National Key Research and Development Program of China (2019YFC1315800)
National High Level Hospital Clinical Research Funding (2022-PUMCH-B-061)
CAMS Innovation Fund for Medical Sciences (2021-I2M-1-002)
234 Discipline Climbing Plan Project of the First Affiliated Hospital of Naval Military Medical University (2019YXK033)
Article History
Received: 19 July 2022
Accepted: 1 November 2022
First Online: 25 November 2022
Declarations
:
: This project was approved by Peking Union Medical College Hospital (PUMHC) Ethics Committee (No. JS-1490) and Changhai Hospital, Navy Medical University (CHNMU) (No. CHEC2020-113). All patients and healthy control volunteers have given informed consent.
: Not applicable.
: The following authors are employees of Singlera Genomics (Shanghai) Ltd.: Zhixi Su, Qiye He, Chengcheng Ma, Rui Liu. The other authors declare that they have no competing interests.